Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: To Evaluate the Efficacy of Alirocumab for Neoatherosclerosis by Using OCT, in Comparison With Standard Statin Therapy
A clinical trial is evaluating the efficacy of alirocumab compared with standard statin therapy for treating neoatherosclerosis in the coron…
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Relation Among HDL Functionality, Neoatherosclerosis and Target Lesion Revascularization
A completed clinical trial update examining how HDL functionality relates to neoatherosclerosis and the need for target lesion revasculariza…
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Percutaneous Coronary Intervention in Patients witH OrthotoPic hEart Transplantation: the PCI-HOPE a Multicenter Study.
Clinical trial update on a multicenter study evaluating percutaneous coronary intervention in patients following orthotopic heart transplant…
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Utilisation of Telemedicine in Optimal Cardiac Rehabilitation Program in Patients After Myocardial Revascularization [NA]
This clinical trial update describes investigating telemedicine to optimize cardiac rehabilitation after coronary revascularization in patie…
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Evaluation of One-stop Strategy of EVAR and PCI [NA]
A clinical trial update describing a one-stop strategy combining endovascular aneurysm repair and percutaneous coronary intervention, with u…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-05-25FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC. The approval indicates regulatory…
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: The Angioshield Study Feasibility II [NA]
The Angioshield Study Feasibility II trial by Neograft Technologies has completed its feasibility update for Coronary Artery Disease.
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Balloon Inflation and Plaque Morphology in Revascularisation (BURST)
BURST is an update on a trial studying balloon inflation and plaque morphology during coronary revascularization; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial [Phase 3]
Phase 3 trial update evaluating anticoagulation in patients undergoing percutaneous coronary revascularization; the study (NCT02448550) has …
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent Implantation [NA]
The clinical trial NCT03184805 evaluating stopping versus continuing antiplatelet therapy around noncardiac surgery after next-generation dr…
-
CLINICAL_TRIALS research · 2018-05-22Clinical Trial Update: Augmented-Reality CTA Plus Angiography vs Angiography Alone for Guiding PCI in Coronary Lesions - Randomized Study [NA]
A randomized trial compares augmented-reality CTA plus angiography guidance with standard angiography alone for guiding PCI in patients with…
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Evaluation of Coronary Microvascular Dysfunction (EVACORY) [NA]
The EVACORY trial evaluating coronary microvascular dysfunction in coronary artery disease has been completed.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions [NA]
This clinical trial update compares an everolimus-eluting bioresorbable vascular scaffold with an everolimus-eluting metallic stent for long…
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD) [Phase 3]
Phase 3 clinical trial evaluating gadobutrol (Gadavist) enhanced CMRI for detecting coronary artery disease has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD) [Phase 3]
Phase 3 trial results for gadobutrol-enhanced cardiac MRI (Gadavist) to detect coronary artery disease have been posted after the study comp…
-
CLINICAL_TRIALS research · 2018-05-15Clinical Trial Update: Mitral Valve Repair Combined Coronary Artery Bypass Grafting(CABG) Verus CABG Alone on Functional Ischemic Mitral Regurgitation [NA]
Clinical trial comparing mitral valve repair combined with coronary artery bypass grafting (CABG) versus CABG alone for functional ischemic …
-
CLINICAL_TRIALS research · 2018-05-15Clinical Trial Update: Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017
This is a completed multicenter registry evaluating radiation dose estimates for cardiac CT angiography performed in routine clinical practi…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Black Pooling Project
This document reports that the Black Pooling Project clinical trial (NCT00064480), sponsored by the Medical University of South Carolina, in…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
AIM-HIGH trial update on plaque inflammation and dysfunctional HDL in patients with cardiovascular disease; the study has completed.
-
CLINICAL_TRIALS research · 2018-05-14Clinical Trial Update: Impact of Text Messages to Promote Secondary Prevention After Acute Coronary Syndrome [NA]
A clinical trial update evaluating whether text messages can improve secondary prevention after acute coronary syndrome. Sponsored by the Fe…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: User Evaluation Study of SyncVision System With Software v4.X
A user evaluation study of the SyncVision System with software version 4.X for coronary artery disease has been terminated. The sponsor is V…
-
FDA approval · 2018-05-11FDA Approved: AMMONIA N-13 — Supplemental Application (Precision Nuclear LLC)
The FDA approved a supplemental application for Ammonia N-13 submitted by Precision Nuclear LLC, updating the use/labeling of this radiophar…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR) [NA]
A head-to-head clinical trial compared intravenous regadenoson with intravenous adenosine (Adenoscan) for measuring fractional flow reserve …
-
CLINICAL_TRIALS research · 2018-05-11Clinical Trial Update: Performance of a New REsting Pressure Index During Invasive Angiography Compared To Adenosine Hyperemic FFR
This clinical trial entry evaluates a new resting pressure index during invasive angiography and compares it with adenosine-induced FFR. The…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Cardiovascular Health and Texting Messaging (CHAT) Study [NA]
The CHAT study, sponsored by the China National Center for Cardiovascular Diseases, investigates texting-based interventions to improve card…